Member of the board of directors since 2019
Since 2017, Ms Paule De Blois has been President and CEO of SOVAR, a limited partnership organization that supports innovation development and technology transfer for Université Laval and other research centers. She cumulates over twenty-five years experience and hands-on achievements in business and enterprise management, including startups and commercial maturation.
From 2005 to 2017, she held senior executive positions in biotechnology (Vice President of Operations at DiagnoCure) and robotics (Chief Operating Officer of B-Temia), and served as Executive Director for the Quebec Network for Personalized HealthCare.
Over the years, she has been responsible for the development and implementation of new sales and marketing strategies, negotiated and closed several business and clinical collaboration agreements, and implemented new governance and operational frameworks. She also gained first-hand experience in the areas of regulatory affairs, technical and clinical testing, marketing of innovations, US expansions, and corporate finance.
Prior to that, Ms. De Blois held positions of increasing responsibility as Director, Administration at The Prudential of America – Canada; Director of Group Product Marketing for Desjardins Financial Security; and Senior Organizational Communications Advisor at Aon and Mercer.
She is currently a director of Québec Innove and the Mouvement des accélérateurs d'innovtion du Québec, and sits on several committees, such as the Québec committee of Réseau Capital and the Québec Vitae committee.
Ms. De Blois holds an MBA from McGill University, a BA in Political Science from Concordia University and a certificate in Marketing from the University of Quebec in Montreal. In addition, she is a certified corporate director of the College of Administrators of Laval University.